Literature DB >> 26689398

A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study.

Luca Pasina1, Alessandra Marengoni2, Simona Ghibelli2, Flavio Suardi3, Codjo D Djade3, Alessandro Nobili3, Carlotta Franchi3, Gianbattista Guerrini4.   

Abstract

BACKGROUND: Older nursing home residents often have a large number of diseases and frequently require multiple medications; the high consumption of psychotropic drugs is of particular concern. The majority of residents in nursing homes suffer from dementia, and the use of psychotropic drugs in these patients is very high. Prescription for short periods of time only are usually recommended to avoid the risk of adverse drug reactions and potentially severe drug-drug interactions (DDIs).
OBJECTIVES: The aim of this multicenter, prospective study was to optimize the prescription of psychotropic drugs, according to the Beers recommendations, in a sample of older patients living in nursing homes in Italy, through a multicomponent intervention, education of general practitioners, and the use of INTERcheck.
METHODS: The study was run in ten nursing homes in Northern Italy from September 2013 to May 2014 (9 months), with the voluntary participation of 14 general practitioners. Each physician was asked to enroll at least 20 consecutive unselected patients. Three educational interventions ('ex cathedra' presentations) were organized by the researchers involved in the project, and a fourth training session was also held on the use of INTERCheck, a Computerized Prescription Support System (CPSS) developed to optimize drug prescription for older people with multimorbidity. Drug prescription information and sociodemographic characteristics of each patient were collected at three different time points-before the educational and training sessions (T0), after 5 months (T1), and after 9 months (T2).
RESULTS: Among the 272 patients included in the analysis, a significant reduction was observed in the mean number of drugs, and in the percentage receiving psychotropic drugs and potentially inappropriate psychotropic drugs (11.5 and 30.6 %, respectively; p < 0.0001). Patients exposed to at least one potentially severe DDI also decreased from 145 (53.3 %) at the first time point to 87 (32.0 %) at the last time point (p < 0.0001). Results were confirmed in the 181 patients for whom information regarding drug treatment was available at all time points.
CONCLUSIONS: The combination of an educational intervention and the CPSS can achieve a significant reduction in potentially inappropriate psychotropic drug use, psychotropic duplicates, and potentially severe DDIs in nursing homes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26689398     DOI: 10.1007/s40266-015-0336-z

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  37 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.

Authors:  Lisa L Dwyer; Beth Han; David A Woodwell; Elizabeth A Rechtsteiner
Journal:  Am J Geriatr Pharmacother       Date:  2010-02

Review 3.  Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Authors:  Tom Declercq; Mirko Petrovic; Majda Azermai; Robert Vander Stichele; An I M De Sutter; Mieke L van Driel; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

4.  The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

Authors:  Clive Ballard; Maria Luisa Hanney; Megan Theodoulou; Simon Douglas; Rupert McShane; Katja Kossakowski; Randeep Gill; Edmund Juszczak; Ly-Mee Yu; Robin Jacoby
Journal:  Lancet Neurol       Date:  2009-01-08       Impact factor: 44.182

5.  Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia.

Authors:  Renate M Nijk; Sytse U Zuidema; Raymond T C M Koopmans
Journal:  Int Psychogeriatr       Date:  2009-04-16       Impact factor: 3.878

Review 6.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Susan M Patterson; Cathal A Cadogan; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2014-10-07

Review 7.  Drug cessation in complex older adults: time for action.

Authors:  Tischa J M van der Cammen; Chakravarthi Rajkumar; Graziano Onder; Carolyn S Sterke; Mirko Petrovic
Journal:  Age Ageing       Date:  2013-11-12       Impact factor: 10.668

8.  A pharmacy led program to review anti-psychotic prescribing for people with dementia.

Authors:  Anne Child; Amy Clarke; Chris Fox; Ian Maidment
Journal:  BMC Psychiatry       Date:  2012-09-25       Impact factor: 3.630

9.  Improving psychotropic drug prescription in nursing home patients with dementia: design of a cluster randomized controlled trial.

Authors:  Claudia H W Smeets; Martin Smalbrugge; Debby L Gerritsen; Marjorie H J M G Nelissen-Vrancken; Roland B Wetzels; Klaas van der Spek; Sytse U Zuidema; Raymond T C M Koopmans
Journal:  BMC Psychiatry       Date:  2013-11-01       Impact factor: 3.630

10.  Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study.

Authors:  Scott Weich; Hannah Louise Pearce; Peter Croft; Swaran Singh; Ilana Crome; James Bashford; Martin Frisher
Journal:  BMJ       Date:  2014-03-19
View more
  5 in total

1.  Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study.

Authors:  Luca Pasina; Sarah Astuto; Laura Cortesi; Mauro Tettamanti; Carlotta Franchi; Alessandra Marengoni; Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

Review 2.  Clinical and Economic Outcomes of Interventions to Reduce Antipsychotic and Benzodiazepine Use Within Nursing Homes: A Systematic Review.

Authors:  Daniel J Hoyle; Ivan K Bindoff; Lisa M Clinnick; Gregory M Peterson; Juanita L Westbury
Journal:  Drugs Aging       Date:  2018-02       Impact factor: 3.923

3.  Use of Central Nervous System (CNS) Medicines in Aged Care Homes: A Systematic Review and Meta-Analysis.

Authors:  Syed Shahzad Hasan; Syed Tabish Razi Zaidi; Jorabar Singh Nirwan; Muhammad Usman Ghori; Farideh Javid; Keivan Ahmadi; Zaheer-Ud-Din Babar
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

Review 4.  Effectiveness of Interventions to Improve the Anticholinergic Prescribing Practice in Older Adults: A Systematic Review.

Authors:  Mohammed S Salahudeen; Adel Alfahmi; Anam Farooq; Mehnaz Akhtar; Sana Ajaz; Saud Alotaibi; Manal Faiz; Sheraz Ali
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

5.  Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.

Authors:  Dario Cattaneo; Luca Pasina; Aldo Pietro Maggioni; Andrea Giacomelli; Letizia Oreni; Alice Covizzi; Lucia Bradanini; Marco Schiuma; Spinello Antinori; Annalisa Ridolfo; Cristina Gervasoni
Journal:  Drugs Aging       Date:  2020-11-05       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.